It’s Time to Future-Proof Your Covered Entity

The landscape for covered entities is changing quickly, and both the future of your business and the wellness of your patients is on the line.

Drastic federal cuts to the 340B program. Alarming changes to Gilead’s Advancing Access Program. If your organization is a federal grantee or health system providing HIV care and/or prevention services, you know there has never been a more important time to future-proof your program—while still offering the highest standards of compassionate care.

What’s more, how entities provide care to their communities is quickly changing. Per CDC guidelines, providers are encouraged to prescribe PrEP to any patient who asks for it, and to have conversations about PrEP with all sexually active adolescent and adult patients. Telehealth is making care more accessible to rural communities, as well as eliminating some of the barriers and fears for patients who don’t feel comfortable in traditional health care settings.

Simply segmenting care into prevention and care categories is no longer going to cut it and both the future of your business and the wellness of your patients is on the line. A quite from Glen Pietrandoni, SVP Patient and community advocate for AvitaWhat does all that mean for covered entities? It means the landscape is changing quickly, and there is an urgent need to consider the entire health care journey of all your patients, both those who are a part of the LGBTQ+ community and those who are not. Simply segmenting care into prevention and care categories is no longer going to cut it—and both the future of your business and the wellness of your patients is on the line.

 

Ready to read full article in 340B Report? Just click here.

Glen Pietrandoni SVP, Patient & Community Advocacy, Avita

Glen is deeply engaged in Avita’s mission as an industry advocate and thought leader for HIV patient care and the continuation of the 340B program benefiting its patients and partners. He is responsible for networking with pharma and government officials to represent Avita’s views and discuss industry activity. Glen leads the efforts to advance Avita Pharmacy programs and continues to look at educational opportunities that improve the health and lives of the patients Avita serves. He plays a key role as an Avita Culture Advocate in building an inclusive culture through our internal programs and benefits. Glen has a 30-year career overseeing HIV and Hepatitis business and strategy for Walgreens and parent company, Walgreens Boots Alliance (WBA). Prior to WBA, he was the owner of independent pharmacies in the Chicago area. Glen serves on the Board of Pharmacy for the State of Illinois, is Chairman of the Board of Trustees of AIDS United, sits on the board of CV340B, and has earned American Academy of HIV Medicine and Apexus 340B certificates. He received a B.S. in Pharmacy from St. Louis College of Pharmacy, St. Louis, Missouri.

Sign up to receive the latest news from Avita Pharmacy